Twist Bioscience reports GLP-1R antagonist antibody as a treatment for congenital hyperinsulinism
Twist Bioscience, offering synthetic DNA using its silicon platform, has published preclinical data supporting the potential use of the...
top of page
Browse by category
Search
Browse by tag
bottom of page